The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
Open accessAbstract
Background: The concept of CpG island methylator phenotype (CIMP) is not universally accepted. Even if specific clinicopathological features have been associated with CIMP, investigators often failed to demonstrate a bimodal distribution of the number of methylated markers, which would suggest CIMP as a distinct subtype of colorectal cancer. Previous studies primarily used methylation specific polymerase chain reaction which might detect biologically insignificant low levels of methylation. Aim: To demonstrate a distinct genetic profile of CIMP colorectal cancer using quantitative DNA methylation analysis that can distinguish high from low levels of DNA methylation. Materials and methods: We developed quantitative real time polymerase chain reaction (MethyLight) assays and measured DNA methylation (percentage of methylated reference) of five carefully selected loci (promoters of CACNA1G , CDKN2A (p16), CRABP1 , MLH1 , and NEUROG1 ) in 460 colorectal cancers from large prospective cohorts. Results: There was a clear bimodal distribution of 80 microsatellite instability-high (MSI-H) tumours according to the number of methylated promoters, with no tumours showing 3/5 methylated loci. Thus we defined CIMP as having ⩾4/5 methylated loci, and 17% (78) of the 460 tumours were classified as CIMP. CIMP was significantly associated with female sex, MSI, BRAF mutations, and wild-type KRAS . Both CIMP MSI-H tumours and CIMP microsatellite stable (MSS) tumours showed much higher frequencies of BRAF mutations (63% and 54%) than non-CIMP counterparts (non-CIMP MSI-H (0%, p<10 −5 ) and non-CIMP MSS tumours (6.6%, p<10 −4 ), respectively). Conclusion: CIMP is best characterised by quantitative DNA methylation analysis. CIMP is a distinct epigenotype of colorectal cancer and may be less frequent than previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
MethyLight: a high-throughput assay to measure DNA methylation
Eads, C. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.e32 · Cited by 1,424
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers
Samowitz, W. S., Sweeney, C., Herrick, J., Albertsen, H., Levin, T. R., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0404 · Cited by 737
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
Kambara, T., Simms, L. A., Whitehall, V. L. J., Spring, K. J., Wynter, C. V. A., Walsh, M. D., Barker, M. A., Arnold, S., McGivern, A., Matsubara, N., et al. (2004) · Gut · doi:10.1136/gut.2003.037671 · Cited by 722
The Nurses׳ Health Study: lifestyle and health among women
Colditz, G. A., & Hankinson, S. E. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1608 · Cited by 590
Samowitz, W. S., Albertsen, H., Herrick, J., Levin, T. R., Sweeney, C., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.020 · Cited by 577
Esteller, M., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., Watkins, D. N., Issa, J. J., Sidransky, D., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 542
Epigenetic patterns in the progression of esophageal adenocarcinoma.
Eads, C. A., Lord, R. V., Wickramasinghe, K. S., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., et al. (2001) · PubMed · Cited by 500
Self-citationMGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer
Shen, L., Kondo, Y., Rosner, G. L., Xiao, L., Hernandez, N. S., Vilaythong, J., Houlihan, P. S., Krouse, R. S., Prasad, A. R., Einspahr, J. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji275 · Cited by 498
Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing
Ogino, S., Kawasaki, T., Brahmandam, M., Yan, L., Cantor, M., Namgyal, C., Mino-Kenudson, M., Lauwers, G. Y., Loda, M., & Fuchs, C. S. (2005) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60571-5 · Cited by 486
Self-citationDistinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
Toyota, M., Ohe-Toyota, M., Ahuja, N., & Issa, J.-P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.710 · Cited by 473
Ogino, S., Kawasaki, T., Brahmandam, M., Cantor, M., Kirkner, G. J., Spiegelman, D., Makrigiorgos, G. M., Weisenberger, D. J., Laird, P. W., Loda, M., et al. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050135 · Cited by 409
Self-citationLaird, P. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi113 · Cited by 398
Self-citationEads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Danenberg, P. V., & Laird, P. W. (1999) · PubMed · Cited by 393
Self-citationHawkins, N., Norrie, M., Cheong, K., Mokany, E., Ku, S., Meagher, A., O'Connor, T., & Ward, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32997 · Cited by 366
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Eads, C. A., Lord, R. V., Kurumboor, S. K., Wickramasinghe, K. S., Skinner, M. L., Long, T. I., Peters, J. H., DeMeester, T. R., Danenberg, K. D., Danenberg, P. V., et al. (2000) · PubMed · Cited by 366
Self-citationGenomic instability and colon cancer
Grady, W. M. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025861527711 · Cited by 353
Epigenetic changes in colorectal cancer
Kondo, Y., & Issa, J.-P. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025806911782 · Cited by 338
Widschwendter, M., Siegmund, K. D., Müller, H. M., Fiegl, H., Marth, C., Müller-Holzner, E., Jones, P. A., & Laird, P. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3852 · Cited by 324
Self-citationEsteller, M., Risques, R. A., Toyota, M., Capellá, G., Moreno, V. R., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 323
van Rijnsoever, M., Elsaleh, H., Joseph, D. J., McCaul, K. A., & Iacopetta, B. J. (2003) · UWA Profiles and Research Repository (UWA) · Cited by 282
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., & Iacopetta, B. (2002) · Gut · doi:10.1136/gut.51.6.797 · Cited by 256
Multiple Mutation Analyses in Single Tumor Cells with Improved Whole Genome Amplification
Dietmaier, W., Hartmann, A., Wallinger, S., Heinmöller, E., Kerner, T., Endl, E., Jauch, K.-W., Hofstädter, F., & Rüschoff, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65254-6 · Cited by 255
Ogino, S., Brahmandam, M., Cantor, M., Namgyal, C., Kawasaki, T., Kirkner, G., Meyerhardt, J. A., Loda, M., & Fuchs, C. S. (2006) · Modern Pathology · doi:10.1038/modpathol.3800482 · Cited by 252
Self-citationFrequent CpG Island Methylation in Serrated Adenomas of the Colorectum
Park, S.-J., Rashid, A., Lee, J.-H., Kim, S. G., Hamilton, S. R., & Wu, T.-T. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63878-3 · Cited by 240
CpG Island Methylation in Aberrant Crypt Foci of the Colorectum
Chan, A. O.-O., Broaddus, R. R., Houlihan, P. S., Issa, J.-P. J., Hamilton, S. R., & Rashid, A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61128-5 · Cited by 233
Nagasaka, T., Sasamoto, H., Notohara, K., Cullings, H. M., Takeda, M., Kimura, K., Kambara, T., MacPhee, D. G., Young, J., Leggett, B. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.154 · Cited by 217
Serrated adenoma of the colorectum and the DNA-methylator phenotype
Jass, J. R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0248 · Cited by 191
Genetics supersedes epigenetics in colon cancer phenotype
Yamashita, K., Dai, T., Dai, Y., Yamamoto, F., & Perucho, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00190-9 · Cited by 188
Concordant CpG Island Methylation in Hyperplastic Polyposis
Chan, A. O.-O., Issa, J.-P. J., Morris, J. S., Hamilton, S. R., & Rashid, A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64872-9 · Cited by 182
Ogino, S., Meyerhardt, J. A., Cantor, M., Brahmandam, M., Clark, J. W., Namgyal, C., Kawasaki, T., Kinsella, K., Michelini, A. L., Enzinger, P. C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0738 · Cited by 162
Self-citationToyota, M., Ho, C., Ohe-Toyota, M., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 154
Zeschnigk, M., Böhringer, S., Price, E., Onadim, Z., Maßhöfer, L., & Lohmann, D. R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh122 · Cited by 150
CpG island methylation in gastroenterologic neoplasia: A maturing field
Rashid, A., & Issa, J. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.007 · Cited by 143
Whitehall, V., Wynter, C. V. A., Walsh, M. D., Simms, L. A., Purdie, D. M., Pandeya, N., Young, J. P., Meltzer, S. J., Leggett, B., & Jass, J. R. (2002) · PubMed · Cited by 135
The influence of folate and multivitamin use on the familial risk of colon cancer in women.
Fuchs, C. S., Willett, W. C., Colditz, G. A., Hunter, D. J., Stampfer, M. J., Speizer, F. E., & Giovannucci, E. L. (2002) · PubMed · Cited by 132
Self-citationIssa, J. J., Shen, L., & Toyota, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.040 · Cited by 107
Overview of Cancer Epigenetics
Jones, P. A. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.05.001 · Cited by 106
DNA Methylation, Field Effects, and Colorectal Cancer
Giovannucci, E. L., & Ogino, S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji305 · Cited by 81
Self-citationColorectal Cancer "Methylator Phenotype": Fact or Artifact?
Anacleto, C., Leopoldino, A. M., Rossi, B., Soares, F. A., Lopes, A., da Rocha, J. C. C., Caballero, O. L., Camargo, A. A., Simpson, A. J. G., & Pena, S. D. J. (2005) · Neoplasia · doi:10.1593/neo.04502 · Cited by 69
Serrated Adenoma of the Colorectum
Jass, J. R. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63865-5 · Cited by 26
Cited by
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02549.x · Cited by 1,384
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Self-citationLessons from the Cancer Genome
Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308
Epigenetic and genetic features of 24 colon cancer cell lines
Ahmed, D., Eide, P. W., Eilertsen, I. A., Danielsen, S. A., Eknæs, M., Hektoen, M., Lind, G. E., & Lothe, R. A. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.35 · Cited by 910
Metadata
- Authors
- Ogino, S., Cantor, M., Kawasaki, T., Brahmandam, M., Kirkner, G. J., Weisenberger, D. J., Campan, M., Laird, P. W., Loda, M., & Fuchs, C. S.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2006-01-11
- Volume
- 55
- Issue
- 7
- Pages
- 1000-1006
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2105307866
- Cited by
- 359
- References
- 44
- FWCI
- 27.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.